Mitogenic and metabolic effects of type I IGF receptor overexpression in insulin receptor-deficient hepatocytes

Endocrinology

Volumn 142, Issue 8, 2001, Pages 3354-3360

  Kim, Jane J ^a   Park, Byung Chul ^a   Kido, Yoshiaki ^a   Accili, Domenico ^a,b  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b Russ Berrie Medical Sciences Pavilion   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; PHOSPHATIDYLINOSITOL 3 KINASE; SOMATOMEDIN; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; GLYCOGEN SYNTHESIS; LIVER CELL; LIVER METABOLISM; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0034924351     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.8.8332     Document Type: Article

References (51)

1. Insulin-like growth factor I receptor signaling-overlapping or redundant pathways?
2. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene
3. Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality
4. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r)
5. Targeted gene mutations define the roles of insulin and IGF-I receptors in mouse embryonic development
6. Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development
7. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells
8. Insulin-like growth factor II stimulates cell proliferation through the insulin receptor
9. Insulin-like growth factor-I and diabetes. A review
10. Role of insulin-like growth factor binding proteins in controlling IGF actions
11. Role of the time factor in signaling specificity: Application to mitogenic and metabolic signaling by the insulin and insulin-like growth factor-I receptor tyrosine kinases
12. Substrate specificities of the insulin and insulin-like growth factor 1 receptor tyrosine kinase catalytic domains
13. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways
14. IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3′-kinase
15. Interaction of the molecular weight 85K regulatory subunit of the phosphatidylinositol 3-kinase with the insulin receptor and the insulin-like growth factor-1 (IGF- I) receptor: Comparative study using the yeast two-hybrid system
16. Differential phosphorylation of pp120 by insulin and insulin-like growth factor-1 receptors: Role for the C-terminal domain of the β-subunit
17. Insulin-like growth factor-I stimulates tyrosine phosphorylation of endogenous c-Crk
18. 14-3-3 Proteins interact with the insulin-like growth factor receptor but not the insulin receptor
19. Grb10 interacts differentially with the insulin receptor, insulin-like growth factor I receptor, and epidermal growth factor receptor via the Grb10 Src homology 2 (SH2) domain and a second novel domain located between the pleckstrin homology and SH2 domains
20. Interaction of MAD2 with the carboxyl terminus of the insulin receptor but not with the IGFIR. Evidence for release from the insulin receptor after activation
21. The adapter protein Grb10 associates preferentially with the insulin receptor as compared with the IGF-I receptor in mouse fibroblasts
22. Interaction of a GRB-IR splice variant (a human GRB10 homolog) with the insulin and insulin-like growth factor I receptors. Evidence for a role in mitogenic signaling
23. The Drosophila insulin receptor activates multiple signaling pathways but requires insulin receptor substrate proteins for DNA synthesis
24. Growth and differentiation signals by the insulin-like growth factor 1 receptor in hemopoietic cells are mediated through different pathways
25. Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis
26. IRS-1: Essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells
27. Differential signaling to glycogen synthesis by the intracellular domain of the insulin versus the insulin-like growth factor-1 receptor. Evidence from studies of TrkC-chimeras
28. Differences in signaling properties of the cytoplasmic domains of the insulin receptor and insulin-like growth factor receptor in 3T3-L1 adipocytes
29. Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors
30. Insulin receptor gene expression during development: Developmental regulation of insulin receptor mRNA abundance in embryonic rat liver and yolk sac, developmental regulation of insulin receptor gene splicing, and comparison to abundance of insulin-like growth factor 1 receptor mRNA
31. Evidence that IRS-2 phosphorylation is required for insulin action in hepatocytes
32. Differential signaling of Insulin and IGF-I receptors to glycogen synthesis in murine hepatocytes
33. Immortalization of cell lines from transgenic and knocout mice by viral transformation
34. Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a wortmannin-sensitive pathway
35. Differential regulation of gene expression by insulin and IGF-I receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR
36. Role of tyrosine kinase activity in signal transduction by the insulin- like growth factor-I (IGF-I) receptor. Characterization of kinase-deficient IGF-I receptors and the action of an IGF-I-mimetic antibody (αIR-3)
37. Tissue-specific insulin resistance in mice with combined mutations of insulin receptor, IRS-1 and IRS-2
38. Phosphoinositide 3-kinase: The key switch mechanism in insulin signalling
39. Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes
40. New insights into the role and mechanism of glycogen synthase
41. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes
42. Insulin-like growth factor I receptor primary structure: Comparison with insulin receptor suggests structural determinants that define functional specificity
43. Insulin/IGF-I hybrid receptors: Implications for the dominant-negative phenotype in syndromes of insulin resistance
44. Receptors for insulin and insulin-like growth factor-I can form hybrid dimers. Characterisation of hybrid receptors in transfected cells
45. The insulin-like growth factor-I receptor. Structure, ligand-binding mechanism and signal transduction
46. The mechanism of insulin action
47. Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds
48. Contrasting effects of IRS-1 versus IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo
49. Disruption of IRS-2 causes type 2 diabetes in mice
50. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice
51. The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans